AZS chart, page-679

First 679 Last

Share
Profile

Follow
gbgirl

5,458 Posts.

1597

27/04/23

19:23

Post #: 67488451
Share

Originally posted by OZTA ↑

big players , traders , whoever generally attempt to force the SP down when we aren’t expecting an announcement anytime soon. They do this by camouflaging the sell orders with 100k+ sell units to create fear, allowing them to accumulate. There was a nice 50k (dollars) buy order in the last hour of trading.

this stunt happened before, when AZS announced the deal with SQM. I see it happening again now and I’ll play to their tune because I don’t care about the daily pips.

In fact, based on TA, AZS respects the chart. 47c was an obvious sell point for traders… 40c wasn’t a strong enough support, there’s a gap at 34.5 which could be an entry point / top up zone . Maybe I should set “x” amount of shares to trade, but I think I’ll be selling myself short.

It’s demoralising to see people still holding a grudge over the MD’s performance and expecting this lithium story to have the same outcome. If we didn’t have SQM, MAY BE I would think the same .

what’s in the ground isn’t going to change just because TR sold Mexican assets too cheap or the share price hasn’t moved in “x” years or because we are forced to read poster’s sulk.

if 30s come into play again, I’ll happily buy because nothing has changed in the last week… except Mr long’s sentiment, as if we actually care lol.

sorry for the long message, just finished exercising and the caffeine hasn’t worn off.

Expand

just remember with this time of year tax loss will come into effect ioho!?!

AZS Price at posting: 38.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

PAM

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

SGP

Things finally 'looking different' for up-and-down Hot Stock tip Stockland

RAD

Radiopharm extends radioimmunotherapy trial to 5 more cancer types